biolover Posted - 11 hours ago

$VKTX $MDGL BL will not sit down on Vk2809 and watch it. Look at mdgl valuation with vk2809 being a better drug ( data c/w that from preclinical to phase 1 and 2 , and not even using daily 5 mg most effective dose in phase 2 ). He just mentioned being swamped with getting vk2735 two massive phase 3 trials starting. We should hear something good in q1 on 2809 whether partnership or initiation of phase 3 . Viking ran a large phase 2 with biopsy and they have the expertise and money to run a slightly larger phase 3 for approval.

Alligator Posted - 15 hours ago

$MDGL Merry Christmas all! I wish you all a Happy New and a Q1 BO 🌲🌲!

THRb Posted - 1 day ago

$MDGL I had a lot of MDGL shares (still have a few) and now I'm picking up GALT because it is oversold from a Martin Shkreli manipulation attack and could get accelerated approval next year. They repeated positive efficacy at the 2mg dose and MASH KOLs now say it is "repeatable" and should continue development. Before you attack me for mentioning a different MASH company, please understand I am a fellow Madrigalite and there is room for more than one company to have success in this space. Let's go both MDGL and GALT!!

nonconformist1 Posted - 1 day ago

$MDGL Though things may seem challenging now, it’s all part of the journey

Alligator Posted - 1 day ago

$MDGL

tttggg Posted - 4 days ago

@Theflash88 $MDGL is my guess

Ag_0018 Posted - 4 days ago

$AKRO dont sleep on AKERO... Phase 2B Symmetry result is coming out in February... $MDGL $VKTX $LLY

All_just_a_game Posted - 4 days ago

$MDGL Big Daddy Paulson. Stake Increases: Madrigal Pharma (MDGL): MDGL is now the largest position by far at ~28% of the portfolio. It was established during Q2 2023 at prices between ~$204 and ~$312. The position was increased by 43% in the next quarter at prices between ~$146 and ~$226. Q4 2023 saw a ~120% stake increase at prices between ~$120 and ~$237. That was followed by a ~60% increase during Q1 2024 at prices between ~$171 and ~$283. This quarter saw a ~10% stake increase at prices between ~$212 and ~$293. The stock currently trades at ~$293. Note: They have a ~10.4% ownership stake in the business.

Alligator Posted - 5 days ago

$MDGL

7Billiards Posted - 5 days ago

$ALT $MDGL incredibly

ImNotLion Posted - 5 days ago

$ALT $MDGL This is the real bottom line. MASH provides a runway for the off label obesity market. Both are gigantic markets. Most contingencies are already satisfied and derisked.

PashaGainz Posted - 5 days ago

$ALT A discussion I've seen brought up a few times already has been ALT pursuing MASH, what that means and how it affects the overall situation... Here are my 2 cents: There are a few components to this. 1) ALT has a MASH drug that beats out really the only other competition out there $MDGL by a fairly substantial margin. I believe the Q2 MRI data will be the final confirmatory data. I believe MDGL is currently hovering around 6B MCAP on a drug that is inferior to Pemv. This can only conclude that off MASH alone we could see 5-6B MCAP especially with a superior drug. 2) Garg has made it a point to mention that we can and will tackle MASH solo if there is not a deal providing FULL VALUE for our product. This is incredibly bullish for multiple reasons. 3) Along with our MASH indication Garg has made it clear that continued obesity metrics would be taken MEANING we will kill two birds with one stone. 4) Commercializing MASH is FAR cheaper and far less complex than commercializing obesity. This means we truly can bring Pemv to market solo under the MASH indication and class best metrics to back it. 5) If that occurred, we would also at the same time take a large swath of the obesity market from the current leaders because physicians could easily provide off label scripts of Pemv for Obesity or other indications. @Cryptobearcat please check me on that as I am a finance guy not a healthcare guy. 6) All of this leads me to believe that there is NO WAY BP let's ALT get to market without doing a FULL BO. No BP wants to see ALT as a competitor. The opportunity cost of not buying ALT would far outweigh the cost of buying ALT.

Whiskeyunderthebed Posted - 5 days ago

$MDGL this is broken...

TheBiotechInvestor_ Posted - 6 days ago

$MDGL Selling at a discounted price of at LEAST 20% https://youtu.be/tcHe-K5nC7Q?si=xdaVBf8vE-R_plMS

Trader2004 Posted - 6 days ago

@BlknPare Bull look at $mdgl this is shorts hitting hard bc market correction coming...You talk like it's just VKTX related...

CallThemOut Posted - 6 days ago

$VKTX $MDGL Really? Why? Because they are going to lose market share they didn't even have yet?

Wallst45 Posted - 6 days ago

$VKTX no more GLP-1 advantage ? So NASH/MASH gain attraction now ? Like $MDGL has very bright future

CallThemOut Posted - 1 week ago

$VKTX $ALT $GPCR $TERN $MDGL I thought SP was an indication of the companies business plan execution, at least I thought Viking deserved a higher valuation as some others believe as well compares to the rest of the related stocks. So now,I understand SP might not reflect the true value of VK2735 or anything else in the pipeline. WS jokers and the price targets they pick are all bullsuit. Am I getting you right? I am too fucking stupid to even fuck. 😒

induscapital Posted - 1 week ago

$BMEA $VKTX $SMMT $MDGL Type 2 diabetes data tomorrow for BMEA Hero or Zero?

Whiskeyunderthebed Posted - 1 week ago

$MDGL how is this not green today?

CanadianApe69 Posted - 1 week ago

$TNXP NDA approval and gov grants worth billions 🤑🤑🤑 nfa but this is gunna be like $DRUG and $MDGL . Fomo Monday!

ROARINGLIONN Posted - 1 week ago

$ALLR $GME $MDGL $TNXP love it

TheBiotechInvestor_ Posted - 1 week ago

What a great year to start a Biotech related YouTube channel. 😂 $IOVA $VNDA $ADAP $AUTL $MDGL

CanadianApe69 Posted - 1 week ago

$TNXP not selling! 🚀 🚀 🚀 $GME $MDGL $ALLR

Whiskeyunderthebed Posted - 1 week ago

$MDGL it's amazing how they can bring this down over 50 pts in a month's time on very little volume.

CallThemOut Posted - 1 week ago

$VKTX Seriously? Wtf do you know what Lian is doing next? Amazes me to think dumb shorts know more than the longs. $ALT has possibly 35% short interest and 24K available to short. Really? They know something? Have they seen what the Co has shown in terms of data and compared? Do you have any fucking idea why Viking is really in the 5-7B market cap? Have you seen $MDGL market cap? Who has the next best drug to market? How far is VK2809 followed by about year or less by Pemvidutide. Have you evaluate the MASH market? Compare Rezdiffra, VK2809, and Pemvidutide and evaluate timeliness for their approvals. Evaluate the costs of those trials. Short some more, you love playing with fire, burn your house down. Short $VKTX and $ALT as much as you want, I have nothing but time and will outlive you.

Alligator Posted - 1 week ago

$MDGL

GeorgeBullus Posted - 1 week ago

$TGTX $MDGL Which one will get the BO first?

Biowizard7 Posted - 2 weeks ago

$MDGL Is anyone alive in this thread? Does anyone still believe MDGL is about get bought out? I sure do! $963 here we come.

Alligator Posted - 2 weeks ago

$MDGL